These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 32211964)

  • 1. Association between myocardial hypoxia and fibrosis in hypertrophic cardiomyopathy: analysis by T2* BOLD and T1 mapping MRI.
    Ando K; Nagao M; Watanabe E; Sakai A; Suzuki A; Nakao R; Ishizaki U; Sakai S; Hagiwara N
    Eur Radiol; 2020 Aug; 30(8):4327-4336. PubMed ID: 32211964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Value of Myocardial Fibrosis Parameters Derived from Cardiac Magnetic Resonance Imaging in Risk Stratification for Patients with Hypertrophic Cardiomyopathy.
    Yu T; Cai Z; Yang Z; Lin W; Su Y; Li J; Xie S; Shen J
    Acad Radiol; 2023 Sep; 30(9):1962-1978. PubMed ID: 36604228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.
    White SK; Sado DM; Fontana M; Banypersad SM; Maestrini V; Flett AS; Piechnik SK; Robson MD; Hausenloy DJ; Sheikh AM; Hawkins PN; Moon JC
    JACC Cardiovasc Imaging; 2013 Sep; 6(9):955-62. PubMed ID: 23582361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1.
    Treibel TA; Fridman Y; Bering P; Sayeed A; Maanja M; Frojdh F; Niklasson L; Olausson E; Wong TC; Kellman P; Miller CA; Moon JC; Ugander M; Schelbert EB
    JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):44-54. PubMed ID: 31103587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.
    Swoboda PP; McDiarmid AK; Erhayiem B; Law GR; Garg P; Broadbent DA; Ripley DP; Musa TA; Dobson LE; Foley JR; Fent GJ; Page SP; Greenwood JP; Plein S
    J Cardiovasc Magn Reson; 2017 Feb; 19(1):16. PubMed ID: 28215181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial extracellular volume fraction measurements with MOLLI 5(3)3 by cardiovascular MRI for the discrimination of healthy volunteers from dilated and hypertrophic cardiomyopathy patients.
    Cui Y; Chen Y; Cao Y; Liu J; Song J; Zhang S; Kong X; Han P; Shi H
    Clin Radiol; 2019 Sep; 74(9):732.e9-732.e16. PubMed ID: 31122714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of myocardial extracellular volume fraction evaluation based on cardiac magnetic resonance T1 mapping with T1 long and short in hypertrophic cardiomyopathy.
    Li Y; Liu X; Yang F; Wang J; Xu Y; Fang T; Pu L; Zhou X; Han Y; Chen Y
    Eur Radiol; 2021 Jul; 31(7):4557-4567. PubMed ID: 33449190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncontrast T1ρ dispersion imaging is sensitive to diffuse fibrosis: A cardiovascular magnetic resonance study at 3T in hypertrophic cardiomyopathy.
    Wang K; Zhang W; Li S; Jin H; Jin Y; Wang L; Li R; Yang Y; Zheng J; Cheng J
    Magn Reson Imaging; 2022 Sep; 91():1-8. PubMed ID: 35525524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac magnetic resonance including parametric mapping in acute Takotsubo syndrome: Preliminary findings.
    Dabir D; Luetkens J; Kuetting DLR; Feisst A; Isaak A; Schild HH; Thomas D
    Eur J Radiol; 2019 Apr; 113():217-224. PubMed ID: 30927950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial fibrosis evaluated by diffusion-weighted imaging and its relationship to 3D contractile function in patients with hypertrophic cardiomyopathy.
    Wu R; An DA; Shi RY; Chen BH; Jiang M; Bacyinski A; Han TT; Hu J; Xu JR; Wu LM
    J Magn Reson Imaging; 2018 Oct; 48(4):1139-1146. PubMed ID: 29601139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI T1 Mapping in Hypertrophic Cardiomyopathy: Evaluation in Patients Without Late Gadolinium Enhancement and Hemodynamic Obstruction.
    Xu J; Zhuang B; Sirajuddin A; Li S; Huang J; Yin G; Song L; Jiang Y; Zhao S; Lu M
    Radiology; 2020 Feb; 294(2):275-286. PubMed ID: 31769741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Native T1 mapping and extracellular volume fraction for differentiation of myocardial diseases from normal CMR controls in routine clinical practice.
    Thongsongsang R; Songsangjinda T; Tanapibunpon P; Krittayaphong R
    BMC Cardiovasc Disord; 2021 Jun; 21(1):270. PubMed ID: 34082703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T1 mapping in children and young adults with hypertrophic cardiomyopathy.
    Parekh K; Markl M; Deng J; de Freitas RA; Rigsby CK
    Int J Cardiovasc Imaging; 2017 Jan; 33(1):109-117. PubMed ID: 27659477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.
    Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK
    BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy.
    Sunthankar SD; George-Durrett K; Crum K; Slaughter JC; Kasten J; Raucci FJ; Markham LW; Soslow JH
    J Cardiovasc Magn Reson; 2023 Jul; 25(1):44. PubMed ID: 37517994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The diagnostic value of quantitative imaging for acute myocardial infarction].
    Cui Q; Yu J; Ge X; Gao G; Liu Y; He Q; Cui Q; Wang H; Shen A
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Feb; 34(2):178-182. PubMed ID: 35387725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy.
    Cadour F; Quemeneur M; Biere L; Donal E; Bentatou Z; Eicher JC; Roubille F; Lalande A; Giorgi R; Rapacchi S; Cortaredona S; Tradi F; Bartoli A; Willoteaux S; Delahaye F; Biene SM; Mangin L; Ferrier N; Dacher JN; Bauer F; Leurent G; Lentz PA; Kovacsik H; Croisille P; Thuny F; Bernard M; Guye M; Furber A; Habib G; Jacquier A
    J Cardiovasc Magn Reson; 2023 Feb; 25(1):7. PubMed ID: 36747201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
    Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histogram Analysis of Native T
    Wu CW; Wu R; Shi RY; An DA; Chen BH; Jiang M; Bacyinski A; Rahim A; Deen JM; Hu J; Han TT; Xu JR; Wu LM
    J Magn Reson Imaging; 2019 Mar; 49(3):668-677. PubMed ID: 30142234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.